Adane AA, Alene KA, Koye DN, Zeleke BM (2013). Non-Adherence to Anti-Tuberculosis Treatment and Determinant Factors among Patients with Tuberculosis in Northwest Ethiopia. PLoS ONE 8(11):e78791.
Crossref

Amuha MG, Kutyabami P, Kitutu FE, Odoi-Adome R, Kalyango JN (2009). Non-adherence to anti-TB drugs among TB/HIV co-infected patients in M barara Hospital Uganda: Prevalence and associated factors. Afr. Health Sci. 9 Suppl 1:S8-15.

Bagchi S, Ambe G, Sathiakumar N (2003). Determinants of Poor Adherence to Anti-Tuberculosis Treatment in Mumbai, India. Int. J. Prev. Med. 1(4):223-232.

Bayu B, Abera BM, Tegene L (2016). Prevalence of Pulmonary Tuberculosis and Associated Factors among Prisoners in Wolaita Zone, Southern Ethiopia: Cross-sectional Study. Am. J. Pub. Health Res. 4(4):142-148.

Dye C, Hosseini M, Watt C (2007). Did we reach the 2005 targets for tuberculosis control? Bull. World Health Organ. 85(5):364-369.
Crossref

Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC (2005). Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA 293(22):2767-2775.
Crossref

Federal Ministry of Health (FMOH) (2012). Guidelines for clinical and programmatic management of TB, leprosy and TB/HIV in Ethiopia; Fifth edition.

George LJ (2003). Compliance with medication and directly observed therapy in the treatment of TB in Lesotho. Philadelphia (PA): Faculty of the School of Social Work, University of Pennsylvania; 300 p. PhD dissertation.

Greene JA (2004). An ethnography of non-adherence: Culture, poverty and tuberculosis in urban Bolivia. Cult. Med. Psychiatry 28:401-425.
Crossref

Harries A, Maher D, Graham S (2007). TB/HIV: A Clinical Manual. Geneva, World Health Organization (WHO/HTM/TB/2004.329).

Ibrahim LM, Hadejia IS, Nguku P, Dankoli R, Waziri NE, Akhimien MO, Ogiri S, Oyemakinde A, Dalhatu I, Nwanyanwu O, Nsubuga P (2014). Factors associated with interruption of treatment among Pulmonary Tuberculosis patients in Plateau State, Nigeria, 2011. Pan Afr. Med. J. 17:78.
Crossref

John G, Anna H, Janet A, Walter M, Peter O, Odylia M, Barbara J (2011). Care seeking and attitudes towards treatment compliance by newly enrolled tuberculosis patients in the district treatment program in rural western Kenya, a qualitative study. BMC Public Health 11:515.
Crossref

Kaona FAD, Tuba M, Siziya S, Sikaona L (2004). An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health 4:68.
Crossref

Matebesi Z (2004). The career of the tuberculosis patient living with TB in the free state, SA.Bloemfontein (South Africa): Dept Sociology, Uni of the Free State; 216 p. PhD dissertation.

Sanou A, Dembele M, Theobald S, Macq J (2004). Access and adhering to tuberculosis treatment: Barriers faced by patients and communities in Burkina Faso. Int. J. Tuberc. Lung Dis. 8:1479-1483.

Sardar P, Jha A, Roy D, Roy S, Guha P, Bandyopadhyay D (2009). Intensive phase non-compliance to anti tubercular treatment in patients with HIV-TB coinfection: a hospital-based cross-sectional study. J Commun. Health 35(5):471-478.

Shargie EB, Lindtjørn B (2005). DOTS improve treatment outcomes and service coverage for tuberculosis in South Ethiopia: a retrospective trend analysis BMC Public Health 5:62.
Crossref

Slama K, Tachfouti N, Obtel M, Nejjari C (2012). Factors associated with treatment default by tuberculosis patients in Fez, Morocco.

Tadesse T, Demissie M, Berhane Y, Kebede Y, Abebe M (2013). Long distance travelling and financial burdens discourage tuberculosis DOTs treatment initiation and compliance in Ethiopia: a qualitative study. BMC Public Health 13(1):1.
Crossref

Trajman A, Bastos ML, Belo M, Calaça J, Gaspar J, Dos Santos AM, Dos Santos CM, Brito RT, Wells WA, Cobelens FG, Vassall A, Gomez GB (2016). Shortened first-line TB treatment in Brazil: potential cost savings for patients and health services. BMC Health Services Res. 16:2.

World Health Organization (WHO) (2003). Responding to market failures in tuberculosis control. Science 293(5532):1049-51.

World Health Organization (WHO) (2005). Tuberculosis. Fact sheet N 104 (Revised). Geneva, World Health Organization. Available at: 

View

World Health Organization (WHO) (2006). Guidelines for collaborative TB and HIV programme activities. Geneva, World Health Organization.

World Health Organization (WHO) (2008). Tuberculosis Handbook Second edition Geneva.

World Health organization (WHO) (2011) Global Tuberculosis Control report. Geneva: World Health Organization.

World Health Organization (WHO) (2013). 2013 Global Tuberculosis Control Geneva. 

View

Xu W, Lu W, Zhou Y, Zhu L, Shen H, Wang J (2009). Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study; china. BMC Health Serv. Res. 9:169.
Crossref

Zekariyas SN, Yohannes H, Gacho M, Tadese ET (2013). Patient satisfaction on tuberculosis treatment service and adherence to treatment in public health facilities of Sidama zone, South Ethiopia. BMC Health Serv. Res. 13(5):110.